The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
myriad genetics | 342 |
myrexis | 18 |
myriad pharmaceuticals | 18 |
cytovia | 9 |
gene logic | 5 |
tesaro | 4 |
sividon diagnostics | 3 |
ore pharmaceuticals | 3 |
abbott | 3 |
abbvie | 3 |
myriad genetics | 17 |
tesaro | 1 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
tumor suppressor designated ts10q23.3 | 21 | 1997 |
cancer biomarkers | 19 | 2009 |
methods and materials for assessing loss of heterozygosity | 17 | 2011 |
methods and materials for assessing loss of heterozygosity | 16 | 2010 |
compounds and therapeutical use thereof | 12 | 2003 |
methods and materials for assessing allelic imbalance | 11 | 2011 |
method of analyzing a brca2 gene in a human subject | 11 | 1997 |
method of assaying 5-fu | 10 | 2009 |
compounds for alzheimer's disease | 10 | 2004 |
therapeutic compounds and their use in cancer | 10 | 2006 |